Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane

MeSH terms

• Adult
• Aged
• Antioxidants / pharmacology*
• Cellulose
• Erythrocyte Aging*
• Erythropoietin / therapeutic use*
• Female
• Glutathione / therapeutic use*
• Humans
• Male
• Membranes, Artificial*
• Middle Aged
• Oxidative Stress
• Renal Dialysis*
• Vitamin E / blood
• Vitamin E / pharmacology*